Featured
-
ISH Global Hypertension Practice Guidelines
2020-11-16
Information and resources related to the 2020 ISH Global Hypertension Practice Guidelines
-
ISH Hypertension News
2020-10-28
We are delighted to share with you the October 2020 issue of ISH Hypertension News.
ISH Hypertension News is available online @ http://ish-world.com/news/a/hypertensionnews/, ISSN: 2520-2782
-
ISH Mentorship Podcasts Now Available
2020-08-11
The ISH Mentorship and Training Committee (MTC) has recently produced a series of podcasts focused on mentorship and career development in hypertension.
-
Postponement of MMM 2020
2020-04-01
It is with reluctance and sadness that, due to the global impact of the COVID-19 pandemic, the May Measurement Month (MMM) Global Project Team has made the decision that MMM20 should not take place this year.
We hope that volunteers will understand and support this decision. We look forward to planning MMM21 together.
-
Joint Meeting ESH-ISH 2020 - NEW DATES
2020-03-23
Dear Colleagues,
The organizing committee of the 2020 ESH-ISH Joint Meeting in Glasgow, would like to inform you that in view of the global unprecedented situation related to COVID-19, the ESH-ISH Joint Meeting, has been rescheduled to April 11-14, 2021.
-
A statement from the International Society of Hypertension on COVID-19
2020-03-16
The International Society of Hypertension (ISH) is aware of concern raised by speculation, which was amplified by the media and which suggested that hypertension (raised blood pressure) increases susceptibility to infection with COVID-19. Further speculation reportedly suggested that two commonly used classes of blood pressure lowering agents (ACE-Inhibitors and Angiotensin Receptor Blockers (ARBs)) may worsen the outcome for those who are infected with COVID-19 (1).
The ISH completely endorses the content of two recent statements made by the Council on Hypertension of the European Society of Cardiology and the European Society of Hypertension (2,3) both of which made clear that there is no good evidence to change the use of ACE-inhibitors or ARBs for the management of raised blood pressure in the context of avoiding or treating COVID-19 infection.
-
ISH Awards Announced
2020-02-24
New Awards Supported by the ISH Mentoring and Training Committee and the ISH Women in Hypertension Research Committee Announced.
-
Fundamentals for Implementing a Hypertension Program in Resource-Constrained Settings
2020-02-24
ISH-supported Online Course aims to help program managers and implementers in designing, planning, and implementing a hypertension control program.
-
ISH Partners in Omron Online Academy Hypertension Course
2019-10-18
The ISH is pleased to support our educational partner Omron Heathcare in the launch of a new online curriculum on hypertension.
-
STRIDE BP: ISH Supported initiative for accurate blood pressure measurement
2019-07-11
STRIDE BP provides lists of accurate devices for office, home and ambulatory…
-
Professor Maciej Tomaszewski named ISH President - Elect
2019-06-13
The ISH is pleased to announce that Professor Maciej Tomaszewski is the President-Elect of the Society. He will take up the Presidential office at the conclusion of the ISH/ESH 2020 meeting in Glasgow
You are viewing articles tagged with "During 03/2020".
-
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
A.H. Jan Danser, Murray Epstein, Daniel Batlle
Read More 26/03/2020
-
Joint Meeting ESH-ISH 2020 - NEW DATES
Dear Colleagues,
The organizing committee of the 2020 ESH-ISH Joint Meeting in Glasgow, would like to inform you that in view of the global unprecedented situation related to COVID-19, the ESH-ISH Joint Meeting, has been rescheduled to April 11-14, 2021.
Read More 23/03/2020
-
A statement from the International Society of Hypertension on COVID-19
The International Society of Hypertension (ISH) is aware of concern raised by speculation, which was amplified by the media and which suggested that hypertension (raised blood pressure) increases susceptibility to infection with COVID-19. Further speculation reportedly suggested that two commonly used classes of blood pressure lowering agents (ACE-Inhibitors and Angiotensin Receptor Blockers (ARBs)) may worsen the outcome for those who are infected with COVID-19 (1).
The ISH completely endorses the content of two recent statements made by the Council on Hypertension of the European Society of Cardiology and the European Society of Hypertension (2,3) both of which made clear that there is no good evidence to change the use of ACE-inhibitors or ARBs for the management of raised blood pressure in the context of avoiding or treating COVID-19 infection.
Read More 16/03/2020